{"id":"NCT01888432","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants","officialTitle":"A 24 Month, Randomized, Controlled, Study to Evaluate the Efficacy and Safety of Concentration-controlled Everolimus Plus Reduced Tacrolimus Compared to Standard Tacrolimus in Recipients of Living Donor Liver Transplants and Long Term Extension to Evaluate the Efficacy and Safety of Concentration-controlled Everolimus Plus Reduced Tacrolimus Compared to Standard Tacrolimus in Recipients of Living Donor Liver Transplants in Japan","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-09-25","primaryCompletion":"2016-10-19","completion":"2018-04-21","firstPosted":"2013-06-27","resultsPosted":"2018-11-13","lastUpdate":"2019-03-18"},"enrollment":285,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Liver Transplantation"],"interventions":[{"type":"DRUG","name":"Everolimus + reduced tacrolimus","otherNames":[]},{"type":"DRUG","name":"Standard tacrolimus","otherNames":[]}],"arms":[{"label":"Everolimus + reduced tacrolimus","type":"EXPERIMENTAL"},{"label":"Standard tacrolimus","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this trial was to demonstrate the efficacy and safety of everolimus in combination with reduced tacrolimus, compared to tacrolimus control, in living donor liver transplant recipients.","primaryOutcome":{"measure":"Number of Participants With Composite Efficacy Failure of Treated Biopsy Proven Acute Rejection, Graft Loss or Death in Everolimus With Reduced Tacrolimus Group Compared to Standard Tacrolimus","timeFrame":"12 months post transplantation","effectByArm":[{"arm":"EVR+Reduced TAC","deltaMin":7,"sd":null},{"arm":"TAC Control","deltaMin":8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":11},"locations":{"siteCount":42,"countries":["United States","Canada","Egypt","Germany","India","Italy","Japan","Russia","Saudi Arabia","Singapore","South Korea","Taiwan","Turkey (TÃ¼rkiye)"]},"refs":{"pmids":["29237235"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":83,"n":142},"commonTop":["Diarrhoea","Hypertension","Nasopharyngitis","Pyrexia","Pruritus"]}}